Yasuji Ueda
Chiyoda, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Sentinel Lymph Node-Targeted Therapy by Oncolytic Sendai Virus Suppresses Micrometastasis of Head and Neck Squamous Cell Carcinoma in an Orthotopic Nude Mouse Model.
Journal: Molecular cancer therapeutics
Published: December 16, 2018
Induction of cell fusion/apoptosis in anaplastic thyroid carcinoma in orthotopic mouse model by urokinase-specific oncolytic Sendai virus.
Journal: Head & neck
Published: March 28, 2018
Oncolytic Sendai virus-induced tumor-specific immunoresponses suppress "simulated metastasis" of squamous cell carcinoma in an immunocompetent mouse model.
Journal: Head & neck
Published: March 27, 2018
Novel ALK5 inhibitor TP0427736 reduces TGF-β induced growth inhibition in human outer root sheath cells and elongates anagen phase in mouse hair follicles.
Journal: Pharmacological reports : PR
Published: May 20, 2016
Gene therapy of c-myc suppressor FUSE-binding protein-interacting repressor by Sendai virus delivery prevents tracheal stenosis.
Journal: PloS one
Published: September 02, 2014
Bi-HAC vector system toward gene and cell therapy.
Journal: ACS synthetic biology
Published: August 08, 2014
Non-transmissible Sendai virus vector encoding c-myc suppressor FBP-interacting repressor for cancer therapy.
Journal: World journal of gastroenterology
Published: October 22, 2013
Discovery of 7-methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole (TASP0382088): a potent and selective transforming growth factor-β type I receptor inhibitor as a topical drug for alopecia.
Journal: Chemical & pharmaceutical bulletin
Published: March 02, 2013
Blocking S1P interaction with S1P₁ receptor by a novel competitive S1P₁-selective antagonist inhibits angiogenesis.
Journal: Biochemical and biophysical research communications
Published: January 18, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026